114 related articles for article (PubMed ID: 11606572)
1. Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domains.
Taupin JL; Legembre P; Bitard J; Daburon S; Pitard V; Blanchard F; Duplomb L; Godard A; Jacques Y; Moreau JF
J Biol Chem; 2001 Dec; 276(51):47975-81. PubMed ID: 11606572
[TBL] [Abstract][Full Text] [Related]
2. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
3. Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.
Taupin JL; Miossec V; Pitard V; Blanchard F; Daburon S; Raher S; Jacques Y; Godard A; Moreau JF
J Biol Chem; 1999 May; 274(20):14482-9. PubMed ID: 10318874
[TBL] [Abstract][Full Text] [Related]
4. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.
Pitard V; Taupin JL; Miossec V; Blanchard F; Cransac M; Jollet I; Vernallis A; Hudson K; Godard A; Jacques Y; Moreau JF
J Immunol Methods; 1997 Jul; 205(2):177-90. PubMed ID: 9294600
[TBL] [Abstract][Full Text] [Related]
8. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
10. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
[TBL] [Abstract][Full Text] [Related]
11. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
Blanchard F; Raher S; Duplomb L; Vusio P; Pitard V; Taupin JL; Moreau JF; Hoflack B; Minvielle S; Jacques Y; Godard A
J Biol Chem; 1998 Aug; 273(33):20886-93. PubMed ID: 9694835
[TBL] [Abstract][Full Text] [Related]
12. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
[TBL] [Abstract][Full Text] [Related]
13. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component.
Robledo O; Fourcin M; Chevalier S; Guillet C; Auguste P; Pouplard-Barthelaix A; Pennica D; Gascan H
J Biol Chem; 1997 Feb; 272(8):4855-63. PubMed ID: 9030543
[TBL] [Abstract][Full Text] [Related]
14. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
Vernallis AB; Hudson KR; Heath JK
J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
[TBL] [Abstract][Full Text] [Related]
15. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
[TBL] [Abstract][Full Text] [Related]
16. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
[TBL] [Abstract][Full Text] [Related]
17. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
Liu H; Dan J; Tang S; Wu S
Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
[TBL] [Abstract][Full Text] [Related]
18. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
